Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-03-09 @ 2:10 PM
Study NCT ID:
NCT01773018
Status:
COMPLETED
Last Update Posted:
2016-06-01
First Post:
2013-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors
Sponsor:
Hutchison Medipharma Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2011-504-00AU1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None